Flector
Product Images NDC 50436-1332

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Flector (NDC 50436-1332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Flector 01)

Chemical Structure (Flector 01)
Chemical structure of Diclofenac and Epolamine shown side-by-side. Diclofenac is depicted with two chlorine atoms attached to one benzene ring and a carboxyl group on the other. Epolamine structure includes a pyrrolidinyl-ethanol moiety with an ammonium ion.*
FDA Label Image

Figure 1 (Flector 02)

Figure 1 (Flector 02)
A line graph comparing the percent of patients improved against percent improvement from baseline for Diclofenac Patch versus placebo. The graph includes two lines: one with solid circles representing Diclofenac Patch and another with open squares representing placebo, showing higher patient improvement percentages for Diclofenac Patch across the range.*
FDA Label Image

Figure 2 (Flector 03)

Figure 2 (Flector 03)
A line graph comparing the percent of patients improved versus percent improvement from baseline. It features two lines: one for Diclofenac Patch and one for Placebo, showing higher improvement rates for the Diclofenac Patch across all measured ranges.*
FDA Label Image

Figure 3 (Flector 04)

Figure 3 (Flector 04)
A line graph comparing the percent of patients improved by percent improvement from baseline between Diclofenac Patch and placebo groups. The graph shows two curves, with the Diclofenac Patch consistently having a higher percentage of patients improved than placebo across all levels of improvement from baseline.*
FDA Label Image

Figure 4 (Flector 05)

Figure 4 (Flector 05)
A line graph comparing the percent of patients improved versus percent improvement from baseline for two groups: Diclofenac Patch and Placebo. The graph shows higher patient improvement percentages with the Diclofenac Patch across increasing percent improvement levels.*
FDA Label Image

Label Image (Lbl504361332)

Label Image (Lbl504361332)
Flector Patch 1.3% (Diclofenac epolamine) topical patch packaging label showing 30 patches per package. Label includes manufacturer details, lot number, and expiration date placeholders, with storage instructions to keep at or below 25°C (77°F). The product is distributed by Unit Dose Services.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.